PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)
Clinical trial NCT06430736 · RECRUITING
Trial details
- NCT number
- NCT06430736
- Sponsor
- Insel Gruppe AG, University Hospital Bern
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-01
- Primary completion
- 2026-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.